Literature DB >> 29710711

Frequency and Correlates of Subjective Memory Complaints in Parkinson's Disease with and without Mild Cognitive Impairment: Data from the Parkinson's Disease Cognitive Impairment Study.

Roberta Baschi1, Alessandra Nicoletti2, Vincenzo Restivo3, Deborah Recca1, Mario Zappia2, Roberto Monastero1.   

Abstract

Subjective memory complaints (SMC) may represent the preclinical phase of mild cognitive impairment (MCI) due to Alzheimer's disease. Dementia/MCI have been described with a high prevalence in Parkinson's disease (PD), but whether SMC may predict the development of cognitive impairment has been barely explored. To evaluate the frequency and clinical correlates of isolated SMC (PD-SMC) or within the construct of MCI in subjects with PD, 147 PD patients from the PArkinson's disease COgnitive impairment Study (PACOS) were consecutively recruited for the study. This is a multicenter study involving two Movement Disorder Centers in south Italy. All subjects underwent comprehensive neuropsychological evaluation and PD-MCI was diagnosed according to Litvan's criteria. The Memory Assessment Clinics Questionnaire was used to assess SMC. Logistic regression analysis, adjusted for demographics and significant covariates, was used to evaluate clinical differences between groups. Forty-two (28.6%) individuals presented with PD without SMC and/or MCI (PDw), 40 (27,2%) with PD-SMC, 48 (32,6%) PD-SMC-MCI, and 17 (11,6%) PD-MCI without SMC (PD-MCI). When compared to PDw, PD-SMC was significantly associated with anxiety (OR = 3.93, 95% CI = 1.18-13.03), while PD-SMC-MCI related to motor progression (OR = 5.29, 95% CI = 1.12-24.86), and instrumental disability (OR = 6.98, 95% CI = 2.08-23.38). About 60% of patients showed SMC, in isolation or within the MCI frame. The role of SMC in PD seems to have a different etiology depending on the presence/absence of MCI. In particular, PD-SMC would represent a subjective reaction to the disease, while PD-SMC-MCI would depict motor progression and disability.

Entities:  

Keywords:  Anxiety; Parkinson’s disease; cognitive impairment; disability; motor impairment; subjective complaints

Mesh:

Year:  2018        PMID: 29710711     DOI: 10.3233/JAD-171172

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  8 in total

Review 1.  Meta-Analysis of Cognition in Parkinson's Disease Mild Cognitive Impairment and Dementia Progression.

Authors:  Elizabeth R Wallace; Suzanne C Segerstrom; Craig G van Horne; Frederick A Schmitt; Lisa M Koehl
Journal:  Neuropsychol Rev       Date:  2021-04-16       Impact factor: 7.444

2.  Parkinson's Disease-Mild Cognitive Impairment (PD-MCI): A Useful Summary of Update Knowledge.

Authors:  Davide Maria Cammisuli; Salvatore Massimiliano Cammisuli; Jonathan Fusi; Ferdinando Franzoni; Carlo Pruneti
Journal:  Front Aging Neurosci       Date:  2019-11-08       Impact factor: 5.750

3.  Cognitive impairment and levodopa induced dyskinesia in Parkinson's disease: a longitudinal study from the PACOS cohort.

Authors:  Antonina Luca; Roberto Monastero; Roberta Baschi; Calogero Edoardo Cicero; Giovanni Mostile; Marco Davì; Vincenzo Restivo; Mario Zappia; Alessandra Nicoletti
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

4.  Subjective Cognitive Complaints in Newly-Diagnosed Parkinson's Disease With and Without Mild Cognitive Impairment.

Authors:  Chenxi Pan; Jingru Ren; Ping Hua; Lei Yan; Miao Yu; Yajie Wang; Gaiyan Zhou; Ronggui Zhang; Jiu Chen; Weiguo Liu
Journal:  Front Neurosci       Date:  2021-11-24       Impact factor: 4.677

5.  Neural correlates and predictors of subjective cognitive decline in patients with Parkinson's disease.

Authors:  Anja Ophey; Fabian Krohm; Carsten Eggers; Franziska Maier; Elke Kalbe; Andrea Greuel; Alexander Drzezga; Marc Tittgemeyer; Lars Timmermann; Frank Jessen
Journal:  Neurol Sci       Date:  2021-11-25       Impact factor: 3.830

6.  Prevalence and affective correlates of subjective cognitive decline in patients with de novo Parkinson's disease.

Authors:  Ning Yang; Yuanyuan Ju; Jingru Ren; Haidong Wang; Peishan Li; Houxu Ning; Jiaping Tao; Weiguo Liu
Journal:  Acta Neurol Scand       Date:  2022-06-20       Impact factor: 3.915

7.  Transcranial random noise stimulation over the primary motor cortex in PD-MCI patients: a crossover, randomized, sham-controlled study.

Authors:  Roberto Monastero; Roberta Baschi; Alessandra Nicoletti; Laura Pilati; Lorenzo Pagano; Calogero Edoardo Cicero; Mario Zappia; Filippo Brighina
Journal:  J Neural Transm (Vienna)       Date:  2020-09-23       Impact factor: 3.575

8.  Vascular risk factors, white matter lesions and cognitive impairment in Parkinson's disease: the PACOS longitudinal study.

Authors:  Alessandra Nicoletti; Antonina Luca; Roberta Baschi; Calogero Edoardo Cicero; Giovanni Mostile; Marco Davì; Giuseppe La Bianca; Vincenzo Restivo; Mario Zappia; Roberto Monastero
Journal:  J Neurol       Date:  2020-08-31       Impact factor: 4.849

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.